OPK
OPKO Health, Inc.NASDAQHealthcare$1.14+0.88%ClosedMarket Cap: $875.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.71
P/S
1.49
EV/EBITDA
-20.02
DCF Value
$0.21
FCF Yield
-21.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
41.5%
Operating Margin
-19.3%
Net Margin
-37.2%
ROE
-17.4%
ROA
-11.7%
ROIC
-6.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $148.5M | 59.6% | $-38.3M | $-31.3M | $-0.04 | — |
| FY 2025 | $606.9M | 21.1% | $-219.0M | $-225.7M | $-0.30 | — |
| Q3 2025 | $151.7M | 47.0% | $48.1M | $21.6M | $0.03 | — |
| Q2 2025 | $156.8M | 31.5% | $-60.0M | $-148.4M | $-0.22 | — |
| Q1 2025 | $150.0M | 28.4% | $-67.2M | $-67.6M | $-0.10 | — |
| Q4 2024 | $183.6M | 46.1% | $-33.1M | $14.0M | $0.02 | — |
| FY 2024 | $713.1M | 43.6% | $-152.1M | $-53.2M | $-0.08 | — |
| Q3 2024 | $173.6M | 23.1% | $14.2M | $24.9M | $0.03 | — |
| Q2 2024 | $182.2M | 28.4% | $-61.7M | $-10.3M | $-0.01 | — |
| Q1 2024 | $173.7M | 24.2% | $-71.5M | $-81.8M | $-0.12 | — |
| Q4 2023 | $181.9M | 24.6% | $-69.0M | $-66.5M | $-0.09 | — |
| FY 2023 | $863.5M | 36.8% | $-157.0M | $-188.9M | $-0.25 | — |